Axon Enterprise (AXON) Stock Forecast & Price Target

Axon Enterprise is attractive because its integrated hardware-and-software ecosystem is still expanding market share in bodycams, TASER, and adjacent subscription products, which should deepen cross-sell into Officer Safety Plan, AI, 911, Fusus, and Dedrone. Fundamental momentum remains strong, with ARR of $1.75 billion up 39.8% year over year, net revenue retention at 126%, future contracted backlog at $15.8 billion, and software and services revenue accelerating 43% year over year to $437 million. The outlook is further supported by 20%+ year-to-date bookings growth, AI products surpassing $100 million in ARR, and the $1.2 billion Skydio investment plus exclusive U.S. and Canada public safety distribution partnership that broadens its drone platform and widens its addressable market.

Axon Enterprise is facing a weaker fundamental setup because Q3 revenue and bookings missed expectations, with about $130 million of Federal Dedrone revenue pushed out and roughly $200 million of TCV delays weighing on the 5-year normalized bookings outlook. The company also cut full-year revenue guidance to about $3.61-$3.63 billion, lowered FCF guidance to $350-$400 million, and saw adjusted EBITDA outlook soften to $924-$929 million as inventory builds, higher memory costs, and product-mix pressure compressed margins. Beyond the near-term miss, slower Taser growth, competitive pricing pressure, and uncertainty around federal procurement timing suggest less upside to revenue and profitability than previously expected.